ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,249,903 | +83.8% | 52,188 | +44.5% | 0.06% | +122.2% |
| Q1 2023 | $679,891 | -69.0% | 36,126 | -73.7% | 0.03% | -66.2% |
| Q4 2022 | $2,189,876 | -48.2% | 137,555 | -46.7% | 0.08% | -46.3% |
| Q3 2022 | $4,226,000 | +1610.9% | 258,297 | +1371.3% | 0.15% | +2028.6% |
| Q2 2022 | $247,000 | -60.3% | 17,556 | -34.1% | 0.01% | -70.8% |
| Q4 2021 | $622,000 | +67.2% | 26,637 | +18.8% | 0.02% | +71.4% |
| Q3 2021 | $372,000 | -91.1% | 22,426 | -86.1% | 0.01% | -89.2% |
| Q1 2021 | $4,177,000 | +21.8% | 161,892 | +152.4% | 0.13% | +14.0% |
| Q4 2020 | $3,429,000 | – | 64,134 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |